CrowdStrike To Surge Nearly 25%? Here Are 10 Notable Analyst Calls From Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Mizuho raised the price target for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from $630 to $700 while maintaining an Outperform rating. CrowdStrike Holdings shares closed at $747.61 on Wednesday. See how other analysts view this stock.
• Susquehanna raised the price target for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from $475 to $800 while maintaining a Positive rating. CrowdStrike Holdings shares closed at $747.61 on Wednesday. See how other analysts view this stock.
• Gordon Haskett lowered the price target for Ollie’s Bargain Outlet Holdings Inc. (NASDAQ:OLLI) from $100 to $90 and downgraded the stock to Accumulate. Ollie’s Bargain Outlet shares closed at $79.74 on Wednesday. See how other analysts view this stock.
• BofA Securities raised the price target for XPO Inc. (NYSE:XPO) from $244 to $246 while maintaining a Buy rating. XPO shares closed at $218.69 on Wednesday. See how other analysts view this stock.
• Baird lowered the price target for Shake Shack Inc. (NYSE:SHAK) from $76 to $60 while maintaining a Neutral rating. Shake Shack shares closed at $55.53 on Wednesday. See how other analysts view this stock.
• Needham raised the price target for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from $475 to $780 while maintaining a Buy rating. CrowdStrike Holdings shares closed at $747.61 on Wednesday. See how other analysts view this stock.
• B of A Securities raised the price target for UnitedHealth Group Inc. (NYSE:UNH) from $420 to $450 and upgraded the stock to Buy. UnitedHealth Group shares closed at $377.00 on Wednesday. See how other analysts view this stock.
• Evercore ISI Group lowered the price target for PVH Corp. (NYSE:PVH) from $95 to $79 and downgraded the stock to In-Line. PVH shares closed at $98.02 on Wednesday. See how other analysts view this stock.
• Ascendiant Capital raised the price target for Vivos Therapeutics Inc. (NASDAQ:VVOS) from $3.00 to $3.10 while maintaining a Buy rating. Vivos Therapeutics shares closed at $0.64 on Wednesday. See how other analysts view this stock.
• Deutsche Bank raised the price target for Spyre Therapeutics Inc. (NASDAQ:SYRE) from $102 to $115 while maintaining a Buy rating. Spyre Therapeutics shares closed at $73.52 on Wednesday. See how other analysts view this stock.